EDGE Therapeutics

Founded in 2009, EDGE Therapeutics is a biotechnology company that raised an IPO in 2015, and was subsequently merged into PDS Biotechnology (NASDAQ: PDSB), a clinical stage biopharmaceutical company with a growing pipeline of cancer immunotherapies and infectious disease vaccines.